Pharmaceutical Product Supply – Oncology Therapeutics

The contract involves the supply of FDA-approved oncology therapeutics in multiple formulations including injectables and solutions, all of which must adhere to strict packaging, labeling, and National Drug Code standards as mandated by the Veterans Affairs Federal Supply Schedule. Products are required to meet all regulatory and compliance benchmarks set forth by the VA to ensure consistency, traceability, and safety in distribution to veterans' healthcare facilities. The agreement falls under NAICS code 325412, indicating specialization in pharmaceutical preparation manufacturing, and is structured as a subcontract under the NAC Federal Supply Schedule 36F797 managed by the Department of Veterans Affairs. Though no solicitation number or detailed point of contact is provided, the posting date of April 27, 2026, signals the anticipated timeline for performance, with fulfillment expected to support VA medical centers nationwide under the established federal supply framework.